TetraLogic Pharmaceuticals Corporation announced the appointment of Mary Ann Gray, Ph.D. and Mr. Michael D. Kishbauch as Class I directors to fill two board slots that have been vacant since January 2014. Since 2003, Dr. Gray has served as President of Gray Strategic Advisors, LLC. From 1999 to 2003, Dr. Gray was Senior Analyst and Portfolio Manager for the Federated Kaufmann Fund.

Mr. Kishbauch served as the Chief Executive Officer and President of Achillion Pharmaceuticals Inc., from July 2004 to May 2013. Prior to joining Achillion, he founded and served as President and CEO of OraPharma Inc.